PA
Panacea Biotec Limited
PANACEABIO.NS · NSE
₹394.00 +4.12% (+₹15.60)
1M -6.41%
Market Cap ₹23.2B
P/E Ratio -
Div. Yield -
ROE 0.86%
Bulios Fair Price
₹255.94
35.0% downside
Trenutna cena
₹394
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica PANACEABIO.NS trenutno precenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Weak
3/9Valuation
27 /100
Expensive P/S 3.45x
P/B 2.78x
EV/EBITDA 202.17x
Growth
63 /100
Stable Book val. growth 0.35%
Rev. growth 11.87%
FCF growth N/A
Profitability
12 /100
Weak Net margin 1.06%
Op. margin 4.52%
FCF margin 3.88%
Quality
7 /100
Poor ROE 0.86%
ROA 0.56%
Asset turnover 0.53x
Debt
76 /100
Low Current ratio 1.47x
Int. coverage -3.34x
Net debt/EBITDA -3.61x
Stability
28 /100
Unstable Rev. volatility 9.94%
EPS volatility 397.91%
Profitable years 0
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o PANACEABIO.NS
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Rajesh Jain
Employees
2,149
Headquarters
New Delhi